iShares Genomics Immunology and Healthcare ETF
About
iShares Genomics Immunology and Healthcare ETF (US46435U1925) is a US-listed equity ETF tracking the NYSE FactSet Global Genomics and Immuno Biopharma Index (USD) (Net). With a expense ratio of 0.47%, its costs are on the higher end for an ETF, paying distributions. The fund holds 69 positions across 9 regions with 168M in assets, with heavy concentration — 59% in United States, 93% in Health Care.
Score Breakdown
Scores are scaled 1–10 on a logarithmic curve relative to all ETFs in the database. Last updated: Jun 22, 2026
| Component | Score | Details |
|---|---|---|
| Cost (30%) | 7.7 | Tracking Difference: 10.0 · TD Consistency: — · Expense Ratio: 2.2 |
| Liquidity (25%) | 6.2 | Assets Under Management |
Data sources: provider factsheets, exchange data, and NAV history. Information for educational purposes only — not investment advice.
Ticker IDNA
ISIN
Fund Size $167.7M
Issuer iShares
Distribution Pays Distributions
Replication Physical
Inception Jun 2019
Base Currency USD
Index NYSE FactSet Global Genomics and Immuno Biopharma Index (USD) (Net)
Asset Class Equities
Category Thematic Equity
Costs
7.7 This fund has low total costs, with competitive tracking and expense ratios.
Expense Ratio0.00%
Expense Ratio0.00%
| Metric | Value |
|---|---|
| Expense Ratio | 0.47% |
Cumulative Returns
Performance across different time periods.
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%
Year to Date+0.00%
1 Year+0.00%
3 Years+0.00%
5 Years+0.00%
Inception+0.00%
| Period | Cumulative Return |
|---|---|
| 1 Month | — |
| 3 Months | — |
| 6 Months | — |
| 1 Year | +49.95% |
| 3 Years | +8.95% |
| 5 Years | -7.76% |
| 10 Years | — |
| YTD | +14.33% |
| Since Inception | +3.77% |
Holdings
This fund invests into 69 individual investments.
View all holdings (50)
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Moderna Inc | MRNA | 514.95% |
| 2 | Twist Bioscience Corp | TWST | 483.15% |
| 3 | REVOLUTION Medicines Inc | RVMD | 417.17% |
| 4 | Bayer AG | BAYN | 396.60% |
| 5 | Biontech Se | BNTX | 394.13% |
| 6 | Genmab A/S | GMAB | 389.22% |
| 7 | Vertex Pharmaceuticals Inc | VRTX | 386.06% |
| 8 | Takeda Pharmaceutical Co Ltd | 4502 | 380.50% |
| 9 | Exelixis Inc | EXEL | 376.22% |
| 10 | Ipsen SA | IPN | 375.87% |
| 11 | GSK PLC | GSK | 375.06% |
| 12 | Roche Holding AG | ROP | 367.13% |
| 13 | Regeneron Pharmaceuticals Inc | REGN | 366.61% |
| 14 | Incyte Corp | INCY | 366.43% |
| 15 | Sanofi SA | SAN | 360.47% |
| 16 | Merck & Co Inc | MRK | 360.06% |
| 17 | ImmunityBio Inc | IBRX | 332.01% |
| 18 | Ideaya Biosciences Inc | IDYA | 311.17% |
| 19 | Caris Life Sciences Inc | CAI | 271.26% |
| 20 | Arcus Biosciences Inc | RCUS | 243.88% |
| 21 | Ono Pharmaceutical Co Ltd | 4528 | 189.00% |
| 22 | CRISPR Therapeutics AG | CRSP | 185.69% |
| 23 | Iovance Biotherapeutics Inc | IOVA | 181.91% |
| 24 | Novavax Inc | NVAX | 170.95% |
| 25 | USD CASH | USD | 165.17% |
| 26 | Nuvation Bio Inc | NUVB | 164.79% |
| 27 | ABCELLERA BIOLOGICS INC | ABCL | 155.54% |
| 28 | Vir Biotechnology Inc | VIR | 146.44% |
| 29 | Kura Oncology Inc | KURA | 102.32% |
| 30 | Janux Therapeutics Inc | JANX | 97.58% |
| 31 | CORVUS PHARMACEUTICALS INC | CRVS | 90.25% |
| 32 | SUNSHINE LAKE PHARMA CO LTD | 6887 | 85.08% |
| 33 | GENFLEET THERAPEUTICS (SHANGHAI) I | 2595 | 84.91% |
| 34 | Intellia Therapeutics Inc | NTLA | 79.58% |
| 35 | Personalis Inc | PSNL | 78.34% |
| 36 | RIGEL PHARMACEUTICALS INC | RIGL | 70.60% |
| 37 | CytomX Therapeutics Inc | CTMX | 61.26% |
| 38 | SHANGHAI HENLIUS BIOTECH INC H | 2696 | 60.51% |
| 39 | DESIGN THERAPEUTICS INC | DSGN | 56.18% |
| 40 | Alvotech SA | ALVO | 52.98% |
| 41 | Ginkgo Bioworks Holdings Inc | DNA | 51.26% |
| 42 | Valneva SE | VLA | 50.93% |
| 43 | OCUGEN INC | OCGN | 49.50% |
| 44 | PACIFIC BIOSCIENCES OF CALIFORNIA | PACB | 48.02% |
| 45 | EUR CASH | EUR | 44.07% |
| 46 | VERASTEM INC | VSTM | 40.45% |
| 47 | ABCLON INC | 174900 | 37.23% |
| 48 | Xencor Inc | XNCR | 33.86% |
| 49 | GBP CASH | GBP | 14.93% |
| 50 | JPY CASH | JPY | 12.79% |
Sectors
Allocation by industry sector.
| Sector | Weight |
|---|---|
| Health Care | 9277.00% |
| Unknown | 723.00% |
Regions
Geographic allocation by country of risk.
| Country | Weight |
|---|---|
| United States | 5885.00% |
| Germany | 791.00% |
| France | 787.00% |
| UNKNOWN | 723.00% |
| Japan | 569.00% |
| Denmark | 389.00% |
| United Kingdom | 375.00% |
| Switzerland | 367.00% |
| China | 61.00% |
| Iceland | 53.00% |
Similar ETFs
Other funds tracking Thematic Equity indices.
iShares U.S. Aerospace & Defense ETF
ITA·Expense Ratio 0.38%
iShares Global Infrastructure ETF
IGF·Expense Ratio 0.39%
iShares Biotechnology ETF
IBB·Expense Ratio 0.44%
iShares U.S. Infrastructure ETF
IFRA·Expense Ratio 0.30%
iShares Future AI & Tech ETF
ARTY·Expense Ratio 0.47%
iShares Global Clean Energy ETF
ICLN·Expense Ratio 0.39%
Feedback
ETFs
Basket
Compare